BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
+0.1%/yr
vs -0.0%/yr prior
5Y CAGR
+1.5%/yr
Consistent
Acceleration
+0.1pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | 97.74% | +0.5% |
| 2024 | 97.23% | -1.4% |
| 2023 | 98.59% | +1.1% |
| 2022 | 97.57% | +2.3% |
| 2021 | 95.38% | +5.3% |
| 2020 | 90.59% | -1.1% |
| 2019 | 91.60% | -6.3% |
| 2018 | 97.72% | +4.8% |
| 2017 | 93.24% | +3.9% |
| 2016 | 89.76% | - |